Related Experiment Video

Updated: Jan 2, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.4K

[Update ESC-Guideline: Management of cardiovascular diseases during pregnancy - What is important?]

Kathrin Klein1, Athanasios Karathanos1, Yvonne Heinen1

  • 1Klinik für Kardiologe, Angiologie und Pneumologie der Universitätsklinik Düsseldorf.

Deutsche Medizinische Wochenschrift (1946)
|December 3, 2019
PubMed

Insights

Managing cardiovascular disease in pregnancy requires careful risk assessment using the World Health Organization classification. This overview highlights updated European Society of Cardiology guidelines for managing heart conditions in expectant mothers.

Area of Science:

  • Cardiology
  • Maternal-Fetal Medicine
  • Public Health

Background:

  • Cardiovascular disease in pregnancy presents unique management challenges.
  • Pre-conception counseling is crucial for cardiac patients based on risk stratification.
  • Existing guidelines require updates to reflect current medical knowledge.

Purpose of the Study:

  • To provide an overview of new and revised recommendations for managing cardiovascular diseases in pregnancy.
  • To summarize key updates from the latest European Society of Cardiology (ESC) guidelines.
  • To inform healthcare providers about best practices in maternal cardiac care.

Main Methods:

  • Review of the latest European Society of Cardiology (ESC) guidelines on cardiovascular diseases during pregnancy.
  • Analysis of updated classifications and risk stratification tools.
  • Synthesis of new or modified management strategies.

Main Results:

  • The updated ESC-Guideline introduces significant changes to the management of pregnant patients with cardiovascular disease.
  • Modified World Health Organization (WHO) classification for maternal cardiovascular risk is emphasized.
  • New recommendations address specific cardiac conditions and their management throughout pregnancy.

Conclusions:

  • Adherence to updated ESC-Guideline recommendations is essential for optimal outcomes in pregnant patients with cardiovascular disease.
  • Risk stratification and individualized management plans are paramount.
  • Continuous medical education on evolving guidelines is necessary for healthcare professionals.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.1K

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
227
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
282
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
285
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
247
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
261